Award
NIH Reporter #3U01AI198071-01S1
Strategy Trial of Personalized Immunomodulatory Therapy for HIV-related Cryptococcal Meningitis
Recipient
University of Minnesota
Award Amount
$314,988.00
Ceiling
$314,988.00
Awarded
September 14, 2026
Identifier
3U01AI198071-01S1
NIH-funded Phase II/III trial investigating individually customized immunotherapy for HIV-related cryptococcal meningitis.
Description
Project to test personalized immunotherapy versus standard antifungal therapy for HIV-related cryptococcal meningitis, including assessment of cerebrospinal fluid inflammation.